Both in Biotechnology
Relay Therapeutics vs Iovance Biotherapeutics
Over the past year RLAY returned +162.8% and IOVA returned +378.0%; their daily moves had a correlation of 0.28.
RLAY +162.8% IOVA +378.0%Growth of $1, one year, split-adjusted
| Metric | RLAY | IOVA |
|---|---|---|
| Price | $18.03 | $8.70 |
| Market cap | $3.95B | $3.94B |
| Today | +3.38% | −1.47% |
| 1 month | −3.8% | −32.9% |
| 6 months | +39.6% | +112.7% |
| Year to date | +113.1% | +218.7% |
| 1 year | +159.8% | +346.2% |
| Revenue growth (YoY) | −48.3% | +65.7% |
| Gross margin | 100.0% | 56.1% |
| Net margin | −23916.3% | −47.6% |
| P/E (TTM) | — | — |
| Price / sales | 381.8× | 12.1× |
| Net cash | $910.9M | $297.7M |
| Dividend yield | — | — |
| Volatility (60d) | 49.2% | 130.2% |
| Short % of float | 27.9% | 15.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).